ODIN Emerging Technologies Presentation_070610 R06

8/9/2019 ODIN Emerging Technologies Presentation_070610 R06

1/41


2/41

They are all constructed from tiny molecular

components called macrocycles Like

stone in the Stone Age, bronze in the

Bronze Age, and iron in the Iron Age,

macrocycles are the building blocks of the21st century the Molecular Age

Chlorophyll (seen above) is a

naturally occurring macrocycle


3/41


4/41

About ODIN Industries

ODIN Industries is a molecular engineering company specialized in

macrocycle compound R&D, technology assessment, new product pipelinedevelopment, and manufacturing. The companys proprietary technology

gives individuals, institutions and companies the ability to exploit vast,

undeveloped chemical space, establish strong patent protection, and deliver

big profit margins on innovative new products that, until now, have had

little or no commercial viability. Through internal and external programs,

licensing, and partnerships, ODIN is working to drive the discovery and

development of pharmaceuticals, advanced materials, fuel cells,

anticorrosives, CO2 sequestration technologies, water purification, and

other important technologies that use macrocycles as key components.


5/41

Growing Your CompanyGrowing Your Company

There arenThere arent many ways to double or triplet many ways to double or triplea companya companys revenues revenue


6/41

and cutting jobs doesnt grow the company


7/41

Your Company Can

But this is

- slow (5-10 years),

- expensive,

- risky, and-likely to afford me too products due to the

need to be first to market

build a new pipeline with internal R&D


8/41


9/41

or Your Company Can Build

better, faster, cheaper!


10/41

Individuals, companies, academic institutions, and

research organizations have discovered countless new

products and technologies that are ready to be

developed, but are too expensive to move through the

pipeline with current research, development and

manufacturing methods.

The Laboratory to Market Dilemmaprovides an opportunity for real growth with first in class products

E = MC2


11/41

Translation $$$$

There exist thousands of under-valued third-party

products and technologies that could benefit

Your Companys pipeline.


12/41

So How Big Is This Opportunity?


13/41

ODIN Industries has developed and patented a

revolutionary new platform technology for the

development and manufacture of a highly sought-after

component called the macrocycle.

Though ODINs technology is a leap-frog technologythat overcomes the obstacles faced in the development

and commercial exploitation of these extraordinary

components, the timing of this breakthrough has created

a very unique opportunity for Your Company - one that

occurs very rarely in history.

From Lab to Life


14/41

Unlike most innovations that have a particular rhythm

as the new technology is born, develops, matures, and

then balloons, ODINs technology provides a platform

to bring an immense back-log of products from the

laboratory to life. Instead of having to wait forproducts to evolve from ODINs technology, market-

ready proto-types will flow rapidly through the

pipeline with the aid of ODINs technology.

Set Your Own Rhythm


15/41

ODINs patented platform technology, called

Dynamic Oligomer Control Cyclization or DOCC,

enables the manufacture of highly sought-after

components that are essential to the development ofcutting edge products from more than eight (8)

diverse industries. Market-ready proto-types, which

currently teeter on the edge of success, can now be

rapidly moved from the laboratory to the market.

Exciting new products ranging from

pharmaceuticals to synthetic fuels; photovoltaic

devices to advanced plastics; and hydrogen fuel cells

to clean water; will quickly emerge with ODINsmacrocycles inside.


16/41

DOCC

cleancoal

aerospacebio-tech

fuelcells

medicaldevices

lubricants

CO2sequestration

defense

anticorrosivepaint

soapsadditives

detergents

synthetic

rubber

plasticsdisease

detection

healthcareflavors &

fragrances

dyes

more to come !

solarenergy

biosensors

With much

waterpurification

first in class

drug leads

greenchemistryODIN Inside


17/41

Just Added

Oil bio-remediation


18/41


19/41

Solar Energy, Automotive, Aerospace, Defense,

Synthetic Rubber, Plastics, Nanotechnology, CO2 Sequestration,Fuel Cells, Batteries, Water Purification, Anti-Corrosives, Crop Science,

Pest control, Animal Health

Just A Few Non-Trivial Markets


20/41

Water PurificationSpecialty chemicals for water treatment - $22 billion globally

PPM-PPT metal sequestration

monitoring, concentrating, removing, recovery reversible

non-reversible

Disinfection/Photodynamic effect

microbes

Bleaching

Destruction of organics

Oil spill bio-remediation


21/41

Healthcare

Antimicrobials

for textiles

bedding

bandages etc.

for hard surfaces

Antibacterials for hard surfaces

Biomaterials

Biosensors

Medical

Agricultural Environmental

Industrial


22/41

Automotive/Transportation

Corrosion Protection ($100 billion)

High Ox/Red

Non-Toxic

Primer & Pigment coats

Fuel Cells

Batteries

Synthetic Rubber

Lubricants

Anti-icing

Self-Cleaning Glass

Advanced materials

Recyclable materials


23/41

Macrocycle-Based Plastics50 billion pounds plus annually

Low Viscosity

Fewer imperfections Lower processing temperatures

No Out-Gassing

Fewer imperfections

Less toxic Consumer Products

Greener

More Advanced Products (Hyper Car Project)

Lighter than steel

More Impact Resistant than Steel

Recyclable


24/41

These macrocycle-based plastics have many advanced properties, and

could replace traditional plastics (more than a 50 billion pound/yearindustry). In addition, macrocycle-based plastics can be used to replace

many heavier steel components in, for example, the aerospace and

transportation industries. These plastics have been highly sought after

by major companies, including Ford and GE, for over two decadesbecause they have the strength of conventional metals, but are 30%

lighter (thus reducing fuel costs), and they are 30% - 60% more impact

resistant so safety is increased dramatically. Unfortunately, the cost of

manufacturing is still 2 to 5 times higher than more traditional

materials, thus most companies are not willing to adopt them at thisprice.

Macrocyclic Plastics


25/41

Soaps, Detergents, Surfactants

Non-peroxide bleaching catalysts

textiles (better bleaching, less dye damage)

wood pulp

Detergents with antiviral, hemolytic, and antibacterial activities

Anti-static agents


26/41

Food & Beverages

Flavors & Fragrances

Food preservatives

Sensing for contamination

Tasting [in color]


27/41

Macrocycle-Based Solar Cells


28/41

Most silicon-based solar cells are very inefficient, typically

around 10%. Although some improvement can be anticipated,the fundamental problem is that silicon-based systems do not

absorb much light. Macrocycle-based solar cells, on the other

hand, are designed using natures own light-absorbing

technology, chlorophyll. Furthermore, macrocycles can beincorporated into other materials such as plastics for ease of

use, and application. Unfortunately, while these macrocyclic

systems are certainly the future of the solar energy industry,

without ODINs technology they will remain much too

expensive to produce on a commercial scale, and will not comeonline for many years into the future.

Solar Energy


29/41

Fueling the Futurefuel cells and batteries


30/41

Fuel Cells & Batteries

A green automotive industry and a green economy willsucceed or fail with the development of ways to store

energy. Fuel cells and batteries are not only necessary for

running our green automobiles, they are necessary for

storing both wind and solar energy for times when the

wind is not blowing and the sun is not shining.

Macrocycle-based technologies show great promise in

both of these areas, but the cost of these products will

keep them out of the hands of the consumer.


31/41

These drugs are used to treat MRSA, C. difficile, and otherhigh profile superbugs. However, they are very difficult to

make, and it is virtually impossible to make analogs

(relatives of the original drug), which are important once

bacteria become resistant to the original drug. It is for this

reason that it has been more than twenty years since the lastnew antibiotic was introduced, and the reason that most

major pharmaceutical companies have abandoned the

antibiotic business.

Peptide Antibiotics


32/41

New Light on MedicinePhotodynamic Therapy (PDT)

Laser Light

Macrocycle

Tumor cell death

Killer Oxygen

Super-Charged Macrocycle-Oxygen complex


33/41

Photodynamic therapy (PDT) is a bimodal treatment for cancer (and otherdiseases), which has few side effects. Unfortunately, the clinical

performance of this treatment has not lived up to expectations. This is due

to the fact that the macrocyclic drugs used in PDT are isolated from nature

as impure substances, and can not be optimized for efficacy. Second and

third generation synthetic macrocycles perform much better than theirnatural counterparts, but they are too expensive to use. Unfortunately,

companies that have pioneered this area are now going out of business and

there is a risk that this technology will be abandoned.

Macrocyclic PDT Drugs


34/41

In yet another emerging crisis, the world-wide

demand for natural rubber will outpace the supply

in less than 5 years, so research on synthetic

rubbers is at a frantic pace. Some synthetic rubbers

are currently being used on high-end performanceand race cars, but the cost is still too high for mass

development and commercialization.

Synthetic Rubber from Macrocycles


35/41

Supply is a serious obstacle to the development of many

promising marine-based therapies. The concentrations of

many highly active compounds in marine invertebrates areoften minute, sometimes accounting for less than 0.1 % of

the wet weight. If one of these compounds were to make it

to the market the annual need for a single compound is

estimated to be roughly 3,00016,000 metric tons ofbiomass per year. It is obvious that such a large amount of

biomass, consisting of either sponges, tunicates or other

pharmacologically promising marine invertebrates, can

never be harvested without risking extinction. Synthetic

strategies for environmentally sound and economicallyfeasible supplies of marine natural products are therefore

needed.

Drugs from the Sea


36/41

ODINs technology makes cutting-edge science and

technology commercially viable now, and accelerates research

in emerging industries that would not otherwise be viable for

many years into the future.

The Bottom Line


37/41

But How Can A Process

Grow Our Business?


38/41

An Ordinary DayAn Ordinary Days Works Work

1000 assembled Model T chassis1000 assembled Model T chassis


39/41

Now imagine if this process did not just apply to one product,

but thousands of new and innovative products!


40/41

ODINS INTELLECTUAL PROPERTY POSITION

ODIN controls proprietary technology relating to the synthesis of macrocyclic compounds and

compounds (ODIN Technology") that is the subject of U.S. Patent Application No. 11/059,796

and many other international applications filed February 17, 2005 in the names of ThomasJohnson and Billy Fowler for Methods, Compositions, and Apparatuses for Forming Macrocyclic

Compounds. Based on a review of the technology incident to patent filing by Intellectual

Property Technology Law (IPTL), Research Triangle Park, NC, AND by the United States Patent

& Trade Office ODINs intellectual property is a novel and fundamental enabling technology for

the manufacture of macrocyclic compounds. The technology resolves a number of basic problems

that have limited the prior commercial synthesis of macrocyclic compounds to small yield andsmall-volume production involving costly and complex purification procedures. By enabling high

yields of macrocyclic compounds to be economically achieved at high volume, the technology

makes these compounds widely available at low costs.

UPDATE 05/04/2010: The first of ODINs patents have issued in theUnited States, Singapore, and Mexico. Many other applications are

patent pending and are expected to issue over the next year.


41/41

ODIN

Pharmaceuticals

BiotechnologySpecialtyChemicals

IndustrialChemicals

AdvancedMaterials

LifeSciences

RenewableEnergy

Nanotechnology

Technology, Vision & Timing

Documents

ODIN Emerging Technologies Presentation_070610 R06